TY - JOUR
T1 - Differential antimicrobial susceptibilities of Granulicatella adiacens and Abiotrophia defectiva
AU - Mushtaq, Ammara
AU - Greenwood-Quaintance, Kerryl E.
AU - Cole, Nicolynn C.
AU - Kohner, Peggy C.
AU - Ihde, Sherry M.
AU - Strand, Gregory J.
AU - Harper, Lance W.
AU - Virk, Abinash
AU - Patel, Robin
N1 - Publisher Copyright:
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
PY - 2016/8
Y1 - 2016/8
N2 - MICs of 25 Abiotrophia defectiva and 109 Granulicatella adiacens isolates were determined by broth microdilution. Using CLSI breakpoints, the susceptibilities of A. defectiva and G. adiacens isolates were, respectively, 24% and 34% to penicillin, 92% and 22% to ceftriaxone, 48% and 3% to cefepime, 72% and 87% to meropenem, 92% and 10% to cefotaxime, 100% and 97% to levofloxacin, 92% and 80% to clindamycin, and 24% and 50% to erythromycin. All isolates were susceptible to vancomycin. In the penicillin-susceptible subgroup, all A. defectiva isolates were susceptible to ceftriaxone; however, 62% of G. adiacens isolates were ceftriaxone nonsusceptible.
AB - MICs of 25 Abiotrophia defectiva and 109 Granulicatella adiacens isolates were determined by broth microdilution. Using CLSI breakpoints, the susceptibilities of A. defectiva and G. adiacens isolates were, respectively, 24% and 34% to penicillin, 92% and 22% to ceftriaxone, 48% and 3% to cefepime, 72% and 87% to meropenem, 92% and 10% to cefotaxime, 100% and 97% to levofloxacin, 92% and 80% to clindamycin, and 24% and 50% to erythromycin. All isolates were susceptible to vancomycin. In the penicillin-susceptible subgroup, all A. defectiva isolates were susceptible to ceftriaxone; however, 62% of G. adiacens isolates were ceftriaxone nonsusceptible.
UR - http://www.scopus.com/inward/record.url?scp=84979224999&partnerID=8YFLogxK
U2 - 10.1128/AAC.00485-16
DO - 10.1128/AAC.00485-16
M3 - Article
C2 - 27216060
AN - SCOPUS:84979224999
SN - 0066-4804
VL - 60
SP - 5036
EP - 5039
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 8
ER -